NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 6 percent increase in its fiscal second quarter revenues on strong growth in its life science segment.

For the three months ended March 31, Meridian's revenues climbed to $54.1 million from $51.3 million, exceeding analysts' consensus estimate of $51.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.